Metastatin: A hyaluronan-binding complex from cartilage that inhibits tumor growth

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1022-1028

  Liu, Ningfei ^a   Lapcevich, Randall K ^b   Underhill, Charles B ^a   Han, Zeqiu ^a   Gao, Feng ^a   Swartz, Glenn ^b   Plum, Stacy M ^b   Zhang, Lurong ^a   Green, Shawn J ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b ENTREMED INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; METASTATIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARTILAGE; CATTLE; CHICK EMBRYO; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE MIGRATION INHIBITION TEST; LUNG CANCER; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION;

ALLANTOIS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CARRIER PROTEINS; CARTILAGE; CATTLE; CELL DIVISION; CELL MOVEMENT; CHICK EMBRYO; CHORION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; HYALURONIC ACID; LUNG NEOPLASMS; LYMPHOKINES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035114425     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The role of hyaluronan in tumor neovascularization
2. Proteoglycans in the microvasculature. II. Histochemical localization in proliferating capillaries of the rabbit cornea
3. Distribution of hyaluronic acid and sulfated glycosaminoglycans during blood vessel development in the chick chorioallantoic membrane
4. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion
5. The distribution of hyaluronate and hyaluronate receptors in the adult lungs
6. Association of hyaluronan with rat vascular endothelial and smooth muscle cells
7. Hyaluronate in vasculogenesis
8. Angiogenesis induced by degradation products of hyaluronic acid
9. Early-response gene signaling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan
10. Hyaluronan-binding protein in endothelial cell morphogenesis
11. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells
12. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
13. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
14. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential
15. Affinity chromatography on immobilized hyaluronate and its applications to the isolation of hyaluronate binding proteins from cartilage
16. Analysis of hyaluronan using biotinylated hyaluronan-binding proteins
17. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
18. Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes
19. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
20. The link protein
21. Angiogenesis
22. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth
23. Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
24. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
25. Isolations of a cartilage factor that inhibits tumor neovascularization
26. Troponin I is present in human cartilage and inhibits angiogenesis
27. Shark cartilage contains inhibitors of tumor angiogenesis
28. Distribution of hyaluronan in the epiphysial growth plate: Turnover by CD44 expressing osteoprogenitor cells
29. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules
30. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
31. Analysis of cell-growth-phase-related variation in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts
32. Induction of hyaluronic acid synthetase activity in rat fibroblasts by medium change of confluent cultures
33. The effect of cell density on net rates of glycosaminoglycan synthesis and secretion by cultured rat fibroblasts
34. Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction
35. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells
36. The interaction of hyaluronate with the cell surface: The hyaluronate receptor and the core protein
37. Tissue uptake of circulating hyaluronic acid
38. The properties and turnover of hyaluronan. Laurent, removal of HA from the blood
39. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution
40. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein
41. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function
42. TSG-6, a glycoprotein associated with arthritis, and its ligand hyaluronan exert opposite effects in a murine model of inflammation